ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 521 • 2015 ACR/ARHP Annual Meeting

    Targeted Quantitative Analysis to Identify Citrullinated Peptides in the Synovial Fluid of Patients with Rheumatoid Arthritis

    Min Jueng Kang1, Ji Soo Kim2, Eugene C. Yi1 and Eun Young Lee2, 1Molecular Medicine and Biopharmaceutical Sciences, Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, and College of Medicine or College of Pharmacy, Seoul National University, Seoul, South Korea, 2Division of Rheumatology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea

    Background/Purpose: The protein/peptide citrullination is a post-translational modification and the citrullinated peptide epitopes are recognized by anti-citrullinated protein/peptide antibody (ACPA), which is a major diagnostic…
  • Abstract Number: 522 • 2015 ACR/ARHP Annual Meeting

    The Expression of mRNA for Peptidylarginine Deiminase Type 2 and Type 4 in CD34+ Cells of the Bone Marrow in Rheumatoid Arthritis

    Tatsuo Nagai1, Tetsuya Tomita2, Hideki Yoshikawa2 and Shunsei Hirohata1, 1Rheumatology and Infectious Diseases, Kitasato University School of Medicine, Kanagawa, Japan, 2Department of Orthopedics, Osaka University Graduate School of Medicine, Suita Osaka, Japan

    Background/Purpose: We previously showed that bone marrow (BM) CD34+ cells from rheumatoid arthritis (RA) patients have abnormal capacities to respond to tumor necrosis factor alpha…
  • Abstract Number: 523 • 2015 ACR/ARHP Annual Meeting

    Elevated Antibody Response to Porphyromonas Gingivalis Detected in Sera Years before the Clinical Onset of Rheumatoid Arthritis

    Nastya Kharlamova1, Ulf Bergström2, Natalia Sherina3, Lennart T.H. Jacobsson2,4, Lennart Truedsson5, Karin Lundberg1 and Carl Turesson2, 1Rheumatology Unit, Department of Medicine, Solna, Karolinska Institute, Stockholm, Sweden, 2Rheumatology, Department of Clinical Sciences, Malmö, Lund University, Malmö, Sweden, 3Rheumatology Unit, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden, 4Department of Rheumatology and Inflammation Research, Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden, 5Section of Microbiology, Immunology and Glycobiology, Department of Laboratory Medicine, Lund University, Lund, Sweden

    Background/Purpose: Chronic periodontitis has been associated with rheumatoid arthritis (RA), and Porphyromonas gingivalis has been proposed as the mechanistic link, due to its unique property…
  • Abstract Number: 524 • 2015 ACR/ARHP Annual Meeting

    Plasma Concentrations of Antibodies to Porphyromonas Gingivalis Are Increased before Onset of Symptom of Rheumatoid Arthritis

    Linda Johansson1, Natalia Sherina2, Nastya Kharlamova3, Barbro Larsson2, Lena Israelsson4, Solbritt Rantapaa-Dahlqvist5 and Karin Lundberg3, 11Public Health and Clinical Medicine/Rheumatology, Umeå University, Umeå, Sweden, 22Rheumatology Unit, Department of Medicine, Karolinska Institute, Stockholm, Sweden, 3Rheumatology Unit, Department of Medicine, Solna, Karolinska Institute, Stockholm, Sweden, 4Rheumatology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden, 5Department of Public Health and Clinical Medicine/ Rheumatology, Umeå University, Umeå, Sweden

    Background/Purpose: Chronic periodontitis has been considered as an important determinant in both occurrence and severity of rheumatoid arthritis (RA). It has been hypothesized that citrullination…
  • Abstract Number: 525 • 2015 ACR/ARHP Annual Meeting

    Association Between Fine Specificity of Anti-Citrullinated Peptide Antibodies and High Resolution Computed Tomography Parenchymal Lung Changes in Patients with Early RA

    Vijay Joshua1, Katerina Chatzidionysiou1, Gudrun Reynisdottir1, Aase Haj Hensvold1, Linda Mathsson-Alm2, Monika Hansson3, Leonor Nogueira4, Anders Eklund5, Guy Serre4, Johan Grunewald5 and Anca I Catrina6, 1Rheumatology Unit, Department of Medicine, Solna, Karolinska Institute, Stockholm, Sweden, Stockholm, Sweden, 2ThermoFisher Scientific, Uppsala, Sweden, Uppsala, Sweden, 3Rheumatology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden, 4Unité Différenciation Épidermique et Autoimmunité Rhumatoïde, Unité Mixte de Recherche, INSERM,Toulouse, France, Toulouse, France, 5Division of Respiratory Medicine, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden, Stockholm, Sweden, 6Unit of Rheumatology, Department of Medicine Solna, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden

    Background/Purpose: We previously showed that anti-CCP2 antibodies are associated with parenchymal lung abnormalities in patients with early RA1. This study aims to examine the association…
  • Abstract Number: 526 • 2015 ACR/ARHP Annual Meeting

    Citrullinated Fibrinogen Promotes Bone Marrow Mesenchymal Stem Cells to Assume a Proinflammatory Phenotype

    Yue Sun, Wei Deng, Weiwei Chen, Genhong Yao, Xuebing Feng and Lingyun Sun, Department of Rheumatology and Immunology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China

    Background/Purpose: Mesenchymal stem cells (MSC) are not only immune-inhibitory cells, and may act as pro-inflammatory cells due to lack of a proper “licensing”. The role…
  • Abstract Number: 527 • 2015 ACR/ARHP Annual Meeting

    Characterisation of the Antibody Response to a Citrullinated Peptide – Derived from the Porphyromonas Gingivalis Peptidyl Arginine Deiminase Enzyme – in Patients with Rheumatoid Arthritis

    Nastya Kharlamova1, Xia Jiang2, Natalia Sherina3, Monika Hansson4, K. Lundberg5 and Lars Alfredsson6, 1Rheumatology Unit, Department of Medicine, Solna, Karolinska Institute, Stockholm, Sweden, 2Rheumatology, karolinska institutet, skärholmen, Sweden, 3Rheumatology, karolinska institutet, Stockholm, Sweden, 4Rheumatology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden, 5Karolinska Institute, Stockholm, Sweden, 6The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden

    Background/Purpose: It has been hypothesized that Porphyromonas gingivalis - the only known pathogen to express a citrullinating enzyme (called P.PAD) - is etiologically linked to…
  • Abstract Number: 528 • 2015 ACR/ARHP Annual Meeting

    RA33 Challenges the Paradigm of Autoantigen Selection in Rheumatoid Arthritis

    Maximilian F. Konig1, Jon Giles2, Peter A. Nigrovic3 and Felipe Andrade1, 1Division of Rheumatology, The Johns Hopkins University School of Medicine, Baltimore, MD, 2Rheumatology, Columbia University Medical Center, NY, NY, 3Department of Medicine, Division of Rheumatology, Immunology and Allergy, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA

    Background/Purpose: Antibodies against citrullinated proteins (ACPAs) are the autoimmune hallmark of rheumatoid arthritis (RA), and can precede the onset of symptomatic disease by years. By…
  • Abstract Number: 529 • 2015 ACR/ARHP Annual Meeting

    Immunoglobulin-a and Immunoglobulin-G Isotypes of Anti-CCP Antibodies Are Present in the Sputum of Subjects at Risk for Future Development of RA

    Kristen Demoruelle1, Linh Ho2, Michael H. Weisman3, Ryan W. Gan4, Mark C. Parish1, Marie L. Feser1, Chelsie Fleischer1, Michael Mahler5, Andrea Seaman5, Jill M. Norris4, V. Michael Holers1 and Kevin D. Deane1, 1Division of Rheumatology, University of Colorado School of Medicine, Aurora, CO, 2University of Colorado School of Medicine, Aurora, CO, 3Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA, 4Epidemiology, Colorado School of Public Health, Aurora, CO, 5Inova Diagnostics, San Diego, CA

    Background/Purpose: Serum elevations of anti-CCP prior to inflammatory arthritis (IA) in RA suggest that anti-CCP is generated at a site outside of the joints. Data…
  • Abstract Number: 530 • 2015 ACR/ARHP Annual Meeting

    Immunomodulation of Naïve RA Patients PBMCs with a Multi-Epitope Peptide Derived from Citrullinated Autoantigens

    Smadar Gertel1, Yehuda Shoenfeld2 and Howard Amital3, 1Sheba Medical Center, Zabludowicz Center for Autoimmune Diseases, affiliated to Sackler Faculty of Medicine, Tel-Aviv University, Ramat Gan, Israel, 2Head Dept of Medicine B, Sheba Medical Center, Ramat-Gan, Israel, 3Sheba Medical Center, Tel-Hashomer, Israel

    Background/Purpose: Citrullinated peptides are major targets of disease-specific autoantibodies in rheumatoid arthritis (RA). We generated a multi-epitope citrullinated peptide (Cit-ME), derived from major prevalent citrullinated…
  • Abstract Number: 531 • 2015 ACR/ARHP Annual Meeting

    Immune Responses to Mycobacterium Heat Shock Protein 70 Accompany Self-Reactivity to Human Bip in Rheumatoid Arthritis

    Hirofumi Shoda1, Shuji Sumitomo1, Keishi Fujio2 and Kazuhiko Yamamoto1, 1Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan, 2Department of Allergy and Rheumatology,Graduate School of Medicine, The University of Tokyo, Tokyo, Japan

    Background/Purpose: Molecular mimicry is believed to be an important mechanism of autoimmunity development. We previously demonstrated that imbalance between effector and regulatory T cells specific for BiP, a…
  • Abstract Number: 532 • 2015 ACR/ARHP Annual Meeting

    Plasma Levels of Bone Morphogenetic Protein (BMP) Subgroups and Their Inhibitors (noggin, sclerostin) in Rheumatoid Arthritis Patients and Correlation with Disease Activity, Clinical and Radiographic Progression: Preliminary Results

    Ozge Kockara1, Sebnem Ataman2, Merve Sibel Gungoren3, Filiz Akbiyik3 and Erdem Karabulut4, 1Physical Medicine and Rehabilitation, Ankara University Faculty of Medicine, Ankara, Turkey, 2Rheumatology Department, Ankara University Faculty of Medicine, Ankara, Turkey, 3Medical Biochemistry, Hacettepe University Faculty of Medicine, Ankara, Turkey, 4Biostatistics, Hacettepe University Faculty of Medicine, Ankara, Turkey

    Background/Purpose: Rheumatoid arthritis (RA) is an inflammatory disease that leads to bone erosion. Bone morphogenetic proteins (BMPs) have favourable effects in the recovery of bone…
  • Abstract Number: 533 • 2015 ACR/ARHP Annual Meeting

    The Interferon Gene Signature in Early Rheumatoid Arthritis Demonstrates No Significant Association with Disease Activity

    Faye A H Cooles1, Amy E. Anderson2, Catharien Hilkens3 and John D Isaacs4, 1Musculoskeletal Research Group, Newcastle University, Newcastle upon Tyne, United Kingdom, 2Musculoskeletal Research Group, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom, 3Musculoskeletal Research Group, Newcastle University, Newcastle Upon Tyne, United Kingdom, 4Newcastle University and the Freeman Hospital, Newcastle-upon-Tyne, United Kingdom

    Background/Purpose: An interferon-α gene signature (IGS) has been demonstrated in a number of rheumatological conditions, including rheumatoid arthritis (RA) where it is present in about…
  • Abstract Number: 534 • 2015 ACR/ARHP Annual Meeting

    Antibodies to Malondialdehyde-Acetaldehyde Adducts Are Highly Expressed in Rheumatoid Arthritis Synovial Fluid 

    Rafid Rahman1, Geoffrey M. Thiele2, Andy Hollins3, Michael J. Duryee1, Daniel Anderson3, Bartlett Hamilton4, Kaleb Michaud5, Lynell W. Klassen6 and Ted R. Mikuls3, 1Internal Medicine Division of Rheumatology, University of Nebraska Medical Center, Omaha, NE, 2Omaha VA Medical Center and University of Nebraska Medical Center, Omaha, NE, 3University of Nebraska Medical Center, Omaha, NE, 4University of Nebraska Medical Center and Omaha VA Medical Center, Omaha, NE, 5Rheumatology & Immunology, University of Nebraska Medical Center and National Data Base for Rheumatic Diseases, Omaha, NE, 6Dept of Internal Medicine, Omaha VA Medical Center and University of Nebraska Medical Center, Omaha, NE

    Background/Purpose:   Malondialdehyde-acetaldehyde (MAA) adducts are expressed in synovial tissues in rheumatoid arthritis (RA). Post-translational MAA modifications are pro-inflammatory, promoting robust anti-MAA antibody responses that…
  • Abstract Number: 535 • 2015 ACR/ARHP Annual Meeting

    Taurine As a Biomarker for Prediction of Response to Biologic Therapy in Rheumatoid Arthritis

    Soshi Takahashi1, Jun Saegusa2, Ikuko Naka1, Kosaku Tsuda1, Takaichi Okano1, Kengo Akashi1, Miwa Nishida1, Keisuke Nishimura2, Sho Sendo2, Yo Ueda1, Akira Onishi3, Yoshinori Kogata2, Goichi Kageyama2 and Akio Morinobu2, 1Department of Rheumatology, Kobe University Hospital, Kobe, Japan, 2Rheumatology and Clinical Immunology, Kobe University Graduate School of Medicine, Kobe, Japan, 3Rheumaology and Clinical Immunology, Kobe University Graduate School of Medicine, Kobe, Japan

    Background/Purpose: To identify a serum biomarker for prediction of the response to biologics (Bio) in patients with rheumatoid arthritis (RA), we performed serum metabolomics analysis…
  • « Previous Page
  • 1
  • …
  • 1904
  • 1905
  • 1906
  • 1907
  • 1908
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology